Skip to main content
Top
Published in: Digestive Diseases and Sciences 9/2007

01-09-2007

Effect of 5-HT2 Receptor Blockade on Cadmium-Induced Acute Toxicity

Authors: Konstantinos N. Tzirogiannis, Maria D. Demonakou, George K. Papadimas, Spyridon D. Skaltsas, Georgia A. Manta, Kalliopi T. Kourentzi, Katerina N. Alexandropoulou, Rosa I. Hereti, Michael G. Mykoniatis, Georgios I. Panoutsopoulos

Published in: Digestive Diseases and Sciences | Issue 9/2007

Login to get access

Abstract

The protective effect of 5-HT2 receptor blockade with ketanserin or ritanserin against cadmium liver injury was investigated. Male Wistar rats were injected intraperitoneally with a sublethal dose of cadmium (3.5 mg/kg body weight). Rats were treated with normal saline (group I), ketanserin (3 mg/kg body weight; group II), or ritanserin (3 mg/kg body weight; group III) 2 hr prior and 4 hr after cadmium administration and killed at different time points. Hematoxylin/eosin-stained liver sections were assessed for necrosis, apoptosis, peliosis, mitoses, and inflammatory infiltration. Apoptosis was also quantified by the TUNEL assay. Nonparenchymal liver cells and activated Kupffer cells were identified histochemically. Necrosis, hepatocyte apoptosis, nonparenchymal cell apoptosis, and macroscopic and microscopic peliosis were markedly reduced or minimized in ketanserin- or ritanserin-treated rats. The observed protective effect was almost identical for both ketanserin and ritanserin administration. 5-HT2 receptor blockade exerts a protective effect against acute cadmium-induced hepatotoxicity.
Literature
1.
go back to reference Page AL, Al-Amamy MM, Chang AC (1986) Cadmium: Cadmium in the environment and its entry into terrestrial food chain crops. Foulkes EC (ed). Springer-Verlag, New York, pp 33–74 Page AL, Al-Amamy MM, Chang AC (1986) Cadmium: Cadmium in the environment and its entry into terrestrial food chain crops. Foulkes EC (ed). Springer-Verlag, New York, pp 33–74
2.
go back to reference Goyer RA, Clarkson TW (2001) Toxic effects of metals. In: Klaassen CD (eds) Casarett and Doull's toxicology: The basic science of poisons. McGraw–Hill, New York, pp 811–867 Goyer RA, Clarkson TW (2001) Toxic effects of metals. In: Klaassen CD (eds) Casarett and Doull's toxicology: The basic science of poisons. McGraw–Hill, New York, pp 811–867
3.
go back to reference Ayres RU (1992) Toxic heavy metals: Materials cycle optimization. Proc Natl Acad Sci USA 89:815–820PubMedCrossRef Ayres RU (1992) Toxic heavy metals: Materials cycle optimization. Proc Natl Acad Sci USA 89:815–820PubMedCrossRef
4.
go back to reference Beyersmann D, Hechtenberg S (1997) Cadmium, gene regulation, and cellular signaling in mammalian cells. Toxicol Appl Pharmacol 144:247–261PubMedCrossRef Beyersmann D, Hechtenberg S (1997) Cadmium, gene regulation, and cellular signaling in mammalian cells. Toxicol Appl Pharmacol 144:247–261PubMedCrossRef
5.
go back to reference Lauwerys R (1979) Cadmium in man. In: Webb M (eds) Chemistry, biochemistry and biology of cadmium. Elsevier/North Holland Biomedical Press, Amsterdam, p 433 Lauwerys R (1979) Cadmium in man. In: Webb M (eds) Chemistry, biochemistry and biology of cadmium. Elsevier/North Holland Biomedical Press, Amsterdam, p 433
6.
go back to reference Fowler BA (1991) Other toxic effects. In: Friberg L, Elinder C-G, Kjellstrom T, Nordberg GF (eds) Cadmium and health: A toxicological and epidemiological appraisal. CRC Press, Boca Raton, FL, pp 159–204 Fowler BA (1991) Other toxic effects. In: Friberg L, Elinder C-G, Kjellstrom T, Nordberg GF (eds) Cadmium and health: A toxicological and epidemiological appraisal. CRC Press, Boca Raton, FL, pp 159–204
7.
go back to reference Goyer RA (1996) Toxic effects of metals. In: Klaassen CD (ed) Casarett and Doull's toxicology: The basic science of poisons. McGraw–Hill, New York, pp 691–736 Goyer RA (1996) Toxic effects of metals. In: Klaassen CD (ed) Casarett and Doull's toxicology: The basic science of poisons. McGraw–Hill, New York, pp 691–736
8.
go back to reference Kotsonis FN, Klaassen CD (1977) Toxicity and distribution of cadmium administered to rats at sublethal doses. Toxicol Appl Pharmacol 41:667–680PubMedCrossRef Kotsonis FN, Klaassen CD (1977) Toxicity and distribution of cadmium administered to rats at sublethal doses. Toxicol Appl Pharmacol 41:667–680PubMedCrossRef
9.
go back to reference Dudley RE, Svoboda DJ, Klaassen C (1982) Acute exposure to cadmium causes severe liver injury in rats. Toxicol Appl Pharmacol 65:302–313PubMedCrossRef Dudley RE, Svoboda DJ, Klaassen C (1982) Acute exposure to cadmium causes severe liver injury in rats. Toxicol Appl Pharmacol 65:302–313PubMedCrossRef
10.
go back to reference Dudley RE, Svoboda DJ, Klaassen CD (1984) Time-course of cadmium-induced ultrastructural changes in rat liver. Toxicol Appl Pharmacol 76:150–160PubMedCrossRef Dudley RE, Svoboda DJ, Klaassen CD (1984) Time-course of cadmium-induced ultrastructural changes in rat liver. Toxicol Appl Pharmacol 76:150–160PubMedCrossRef
11.
go back to reference Habeebu SS, Liu J, Klaassen CD (1998) Cadmium-induced apoptosis in mouse liver. Toxicol Appl Pharmacol 149:203–209PubMedCrossRef Habeebu SS, Liu J, Klaassen CD (1998) Cadmium-induced apoptosis in mouse liver. Toxicol Appl Pharmacol 149:203–209PubMedCrossRef
12.
go back to reference Tzirogiannis KN, Panoutsopoulos GI, Demonakou MD, Hereti RI, Alexandropoulou KN, Basayannis AC, Mykoniatis MG (2003) Time-course of cadmium-induced acute hepatotoxicity in the rat liver: The role of apoptosis. Arch Toxicol 77:694–701PubMedCrossRef Tzirogiannis KN, Panoutsopoulos GI, Demonakou MD, Hereti RI, Alexandropoulou KN, Basayannis AC, Mykoniatis MG (2003) Time-course of cadmium-induced acute hepatotoxicity in the rat liver: The role of apoptosis. Arch Toxicol 77:694–701PubMedCrossRef
13.
go back to reference Pulido MD, Parrish AR (2003) Metal-induced apoptosis: mechanisms. Mutat Res 533:227–241PubMed Pulido MD, Parrish AR (2003) Metal-induced apoptosis: mechanisms. Mutat Res 533:227–241PubMed
14.
go back to reference Azmitia EC (2001) Modern views on an ancient chemical: serotonin effects on cell proliferation, maturation and apoptosis. Brain Res Bull 56:413–424PubMedCrossRef Azmitia EC (2001) Modern views on an ancient chemical: serotonin effects on cell proliferation, maturation and apoptosis. Brain Res Bull 56:413–424PubMedCrossRef
15.
go back to reference Barnes NM, Sharp T (1999) A review of central 5-HT receptors and their function. Neuropharmacology 38:1083–1152PubMedCrossRef Barnes NM, Sharp T (1999) A review of central 5-HT receptors and their function. Neuropharmacology 38:1083–1152PubMedCrossRef
16.
go back to reference Lucaites VL, Nelson DL, Wainscott DB, Baez M (1996) Receptor subtype and density determine the coupling repertoire of the 5-HT2 receptor subfamily. Life Sci 59:1081–1095PubMedCrossRef Lucaites VL, Nelson DL, Wainscott DB, Baez M (1996) Receptor subtype and density determine the coupling repertoire of the 5-HT2 receptor subfamily. Life Sci 59:1081–1095PubMedCrossRef
17.
go back to reference Adayev T, El-Sherif Y, Barua M, Penington NJ, Banerjee P (1999) Agonist stimulation of the serotonin 1A receptor cauces suppression of anoxia-induced apoptosis via mitogen-activated protein kinase in neuronal HN2-5 cells. J Neurochem 72:1489–1496PubMedCrossRef Adayev T, El-Sherif Y, Barua M, Penington NJ, Banerjee P (1999) Agonist stimulation of the serotonin 1A receptor cauces suppression of anoxia-induced apoptosis via mitogen-activated protein kinase in neuronal HN2-5 cells. J Neurochem 72:1489–1496PubMedCrossRef
18.
go back to reference Massey MF, Davies MG, Svendsen E, Klyachkin ML, Schwartz LB, Barber L, McCann RL, Hagen PO (1993) Reduction of experimental vein graft intimal hyperplasia by ketanserin. J Surg Res 54:530–538PubMedCrossRef Massey MF, Davies MG, Svendsen E, Klyachkin ML, Schwartz LB, Barber L, McCann RL, Hagen PO (1993) Reduction of experimental vein graft intimal hyperplasia by ketanserin. J Surg Res 54:530–538PubMedCrossRef
19.
go back to reference Pakala R, Willerson JT, Benedict CR (1994) Mitogenic effect of serotonin on vascular endothelial cells. Circulation 90:1919–1926PubMed Pakala R, Willerson JT, Benedict CR (1994) Mitogenic effect of serotonin on vascular endothelial cells. Circulation 90:1919–1926PubMed
20.
go back to reference Cirillo P, Golino P, Ragni M, Battaglia C, Pacifico F, Formisano S, Buono C, Condoreli M, Chiariello M (1999) Activated platelets and leucocytes cooperatively stimulate smooth muscle cell proliferation and proto-oncogene expression via release of soluble growth factors. Cardiovasc Res 43:210–218PubMedCrossRef Cirillo P, Golino P, Ragni M, Battaglia C, Pacifico F, Formisano S, Buono C, Condoreli M, Chiariello M (1999) Activated platelets and leucocytes cooperatively stimulate smooth muscle cell proliferation and proto-oncogene expression via release of soluble growth factors. Cardiovasc Res 43:210–218PubMedCrossRef
21.
go back to reference Hajnoczky G, Csordas G, Madesh M, Pacher P (2000) Control of apoptosis by IP(3) and ryanodine receptor driven calcium signals. Cell Calcium 28:349–363PubMedCrossRef Hajnoczky G, Csordas G, Madesh M, Pacher P (2000) Control of apoptosis by IP(3) and ryanodine receptor driven calcium signals. Cell Calcium 28:349–363PubMedCrossRef
22.
go back to reference Ozaki S, DeWald DB, Shope JC, Chen J, Prestwich GD (2000) Intracellular delivery of phosphoinositides and inositol phosphates using polyamine carriers. Proc Natl Acad Sci USA 97:11286–11291PubMedCrossRef Ozaki S, DeWald DB, Shope JC, Chen J, Prestwich GD (2000) Intracellular delivery of phosphoinositides and inositol phosphates using polyamine carriers. Proc Natl Acad Sci USA 97:11286–11291PubMedCrossRef
23.
go back to reference Schmidt CJ, Black CK, Taylor VL (1990) Antagonism of the neurotoxicity due to a single administration of methylenedioxymethamphetamine. Eur J Pharmacol 181:59–70PubMedCrossRef Schmidt CJ, Black CK, Taylor VL (1990) Antagonism of the neurotoxicity due to a single administration of methylenedioxymethamphetamine. Eur J Pharmacol 181:59–70PubMedCrossRef
24.
go back to reference Leysen JE, Awouters F, Kennis L, Laduron PM, Vandenberk J, Janssen PA (1981) Receptor binding profile of R41468, a novel antagonist at 5–HT2 receptors. Life Sci 28:1015–1022PubMedCrossRef Leysen JE, Awouters F, Kennis L, Laduron PM, Vandenberk J, Janssen PA (1981) Receptor binding profile of R41468, a novel antagonist at 5–HT2 receptors. Life Sci 28:1015–1022PubMedCrossRef
25.
go back to reference Brogden RN, Sorkin EM (1990) Ketanserin: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in hypertension and peripheral vascular disease. Drugs 40:903–949PubMed Brogden RN, Sorkin EM (1990) Ketanserin: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in hypertension and peripheral vascular disease. Drugs 40:903–949PubMed
26.
go back to reference Persson B, Heykants J, Hedner T (1991) Clinical pharmacokinetics of ketanserin. Clin Pharmacokinet 20:263–279PubMed Persson B, Heykants J, Hedner T (1991) Clinical pharmacokinetics of ketanserin. Clin Pharmacokinet 20:263–279PubMed
27.
go back to reference Greek presidential decree No. 160 (1991) Protection of animals used for experimental and other scientific purposes in accordance with EU Directive 86/609/EEC of the Council. Governmental Gazette No. 64 Greek presidential decree No. 160 (1991) Protection of animals used for experimental and other scientific purposes in accordance with EU Directive 86/609/EEC of the Council. Governmental Gazette No. 64
28.
go back to reference Kayama F, Yoshida T, Elwell MR, Luster MI (1995) Role of tumor necrosis factor-alpha in cadmium-induced hepatotoxicity. Toxicol Appl Pharmacol 131:224–234PubMedCrossRef Kayama F, Yoshida T, Elwell MR, Luster MI (1995) Role of tumor necrosis factor-alpha in cadmium-induced hepatotoxicity. Toxicol Appl Pharmacol 131:224–234PubMedCrossRef
29.
go back to reference Dong W, Simeonova PP, Gallucci R, Matheson J, Flood L, Wang S, Hubbs A, Luster MI (1998) Toxic metals stimulate inflammatory cytokines in hepatocytes through oxidative stress mechanisms. Toxicol Appl Pharmacol 151:359–366PubMedCrossRef Dong W, Simeonova PP, Gallucci R, Matheson J, Flood L, Wang S, Hubbs A, Luster MI (1998) Toxic metals stimulate inflammatory cytokines in hepatocytes through oxidative stress mechanisms. Toxicol Appl Pharmacol 151:359–366PubMedCrossRef
30.
go back to reference Rikans LE, Yamano T (2000) Mechanisms of cadmium-mediated acute hepatotoxicity. J Biochem Mol Toxicol 14:110–117PubMedCrossRef Rikans LE, Yamano T (2000) Mechanisms of cadmium-mediated acute hepatotoxicity. J Biochem Mol Toxicol 14:110–117PubMedCrossRef
31.
go back to reference Yamano T, DeCicco LA, Rikans LE (2000) Attenuation of cadmium–induced liver injury in senescent male Fischer 344 rats: Role of Kupffer cells and inflammatory cytokines. Toxicol Appl Pharmacol 162:68–75PubMedCrossRef Yamano T, DeCicco LA, Rikans LE (2000) Attenuation of cadmium–induced liver injury in senescent male Fischer 344 rats: Role of Kupffer cells and inflammatory cytokines. Toxicol Appl Pharmacol 162:68–75PubMedCrossRef
32.
go back to reference Baranski B, Opacka J, Wronska-Nofer T, Trzcinka-Ochocka M, Sitarek K (1983) Effect of cadmium on arterial blood pressure and lipid metabolism in rats. Toxicol Lett 18:245–250PubMedCrossRef Baranski B, Opacka J, Wronska-Nofer T, Trzcinka-Ochocka M, Sitarek K (1983) Effect of cadmium on arterial blood pressure and lipid metabolism in rats. Toxicol Lett 18:245–250PubMedCrossRef
33.
go back to reference Kostrzewska A, Laudanski T, Bergelin I (1991) Influence of cadmium ions on the reactivity of isolated human uterine arteries. J Toxicol Environ Health 34:187–195PubMedCrossRef Kostrzewska A, Laudanski T, Bergelin I (1991) Influence of cadmium ions on the reactivity of isolated human uterine arteries. J Toxicol Environ Health 34:187–195PubMedCrossRef
34.
go back to reference Zhang C, Thind GS, Joshua IG, Fleming JT (1993) Cadmium-induced arteriolar constriction in skeletal muscle microcirculation. Am J Hypertens 6:325–329PubMed Zhang C, Thind GS, Joshua IG, Fleming JT (1993) Cadmium-induced arteriolar constriction in skeletal muscle microcirculation. Am J Hypertens 6:325–329PubMed
35.
go back to reference McCall RB, Clement ME (1994) Role of serotonin 1A and serotonin 2 receptors in the central regulation of the cardiovascular system. Pharmacol Rev 46:231–243PubMed McCall RB, Clement ME (1994) Role of serotonin 1A and serotonin 2 receptors in the central regulation of the cardiovascular system. Pharmacol Rev 46:231–243PubMed
37.
go back to reference Su C, Uruno T (1984) Excitatory and inhibitory effects of 5-hydroxytryptamine in mesenteric arteries of spontaneously hypertensive rats. Eur J Pharmacol 106:283–290PubMedCrossRef Su C, Uruno T (1984) Excitatory and inhibitory effects of 5-hydroxytryptamine in mesenteric arteries of spontaneously hypertensive rats. Eur J Pharmacol 106:283–290PubMedCrossRef
38.
go back to reference Van Nueten JM, Janssens WJ, Vanhoutte PM (1985) Serotonin and vascular reactivity. Pharmacol Res Commun 17:585–608PubMedCrossRef Van Nueten JM, Janssens WJ, Vanhoutte PM (1985) Serotonin and vascular reactivity. Pharmacol Res Commun 17:585–608PubMedCrossRef
39.
go back to reference Vanhoutte PM (1990) Vascular effects of serotonin and ischemia. J Cadiovasc Pharmacol 16(Suppl 3):S15–S19 Vanhoutte PM (1990) Vascular effects of serotonin and ischemia. J Cadiovasc Pharmacol 16(Suppl 3):S15–S19
40.
go back to reference Morcos NC, Grandaw PP, Henry WL, Purdy RE (1991) Modulation of serotonin-induced vasospasm by endothelium and monoamine oxidase. Int J Tissue React 13:19–26PubMed Morcos NC, Grandaw PP, Henry WL, Purdy RE (1991) Modulation of serotonin-induced vasospasm by endothelium and monoamine oxidase. Int J Tissue React 13:19–26PubMed
41.
go back to reference Urabe M, Kawasaki H, Takasaki K (1991) Effect of endothelium removal on the vasoconstrictor response to neuronally released 5-hydroxytryptamine and noradrenaline in the rat isolated mesenteric and femoral arteries. Br J Pharmacol 102:85–90PubMed Urabe M, Kawasaki H, Takasaki K (1991) Effect of endothelium removal on the vasoconstrictor response to neuronally released 5-hydroxytryptamine and noradrenaline in the rat isolated mesenteric and femoral arteries. Br J Pharmacol 102:85–90PubMed
42.
go back to reference Ishida T, Kawashima S, Hirata K, Yokoyama M (1998) Nitric oxide is produced via 5-HT1B and 5-HT2B receptor activation in human coronary artery endothelial cells. Kobe J Med Sci 44:51–63PubMed Ishida T, Kawashima S, Hirata K, Yokoyama M (1998) Nitric oxide is produced via 5-HT1B and 5-HT2B receptor activation in human coronary artery endothelial cells. Kobe J Med Sci 44:51–63PubMed
43.
go back to reference Ozdem SS, Ogutman C (1997) Responsiveness of aortic rings of cadmium–hypertensive rats to endothelin-1. Pharmacology 54:328–332PubMedCrossRef Ozdem SS, Ogutman C (1997) Responsiveness of aortic rings of cadmium–hypertensive rats to endothelin-1. Pharmacology 54:328–332PubMedCrossRef
44.
go back to reference Doi Y, Kudo H, Yamamoto O, Hamasaki K, Yoshizuka M, Fujimoto S (2002) Enhancement of immunoreactivity for endothelin-1 and endothelin-converting enzyme-1 in the cadmium-treated rat thoracic aorta. Virchows Arch 441:179–186PubMedCrossRef Doi Y, Kudo H, Yamamoto O, Hamasaki K, Yoshizuka M, Fujimoto S (2002) Enhancement of immunoreactivity for endothelin-1 and endothelin-converting enzyme-1 in the cadmium-treated rat thoracic aorta. Virchows Arch 441:179–186PubMedCrossRef
45.
go back to reference Okumura S, Takei Y, Kawano S, Nagano K, Masuda E, Goto M, Tsuji S, Michida T, Chen SS, Kashiwagi T (1994) Vasoactive effect of endothelin-1 on rat liver in vivo. Hepatology 19:155–161PubMed Okumura S, Takei Y, Kawano S, Nagano K, Masuda E, Goto M, Tsuji S, Michida T, Chen SS, Kashiwagi T (1994) Vasoactive effect of endothelin-1 on rat liver in vivo. Hepatology 19:155–161PubMed
46.
go back to reference Zhang JX, Pegoli WJr, Clemens MG (1994) Endothelin-1 induces direct constriction of hepatic sinusoids. Am J Physiol 266:G624–G632PubMed Zhang JX, Pegoli WJr, Clemens MG (1994) Endothelin-1 induces direct constriction of hepatic sinusoids. Am J Physiol 266:G624–G632PubMed
47.
go back to reference De Clerck F (1991) Effects of serotonin on platelets and blood vessels. J Cardiovasc Pharmacol 17(Suppl 5):S1–S5PubMed De Clerck F (1991) Effects of serotonin on platelets and blood vessels. J Cardiovasc Pharmacol 17(Suppl 5):S1–S5PubMed
48.
go back to reference Liu J, Kershaw WC, Liu YP, Klaassen CD (1992) Cadmium-induced hepatic endothelial cell injury in inbred strains of mice. Toxicology 75:51–62PubMedCrossRef Liu J, Kershaw WC, Liu YP, Klaassen CD (1992) Cadmium-induced hepatic endothelial cell injury in inbred strains of mice. Toxicology 75:51–62PubMedCrossRef
49.
go back to reference Herrmann KS, Kreuzer H (1990) Effect of serotonergic antagonism on local responses to an acute and selective andothelial trauma in vivo. J Cardiovasc Pharmacol 16(Suppl 3):S40–S44PubMed Herrmann KS, Kreuzer H (1990) Effect of serotonergic antagonism on local responses to an acute and selective andothelial trauma in vivo. J Cardiovasc Pharmacol 16(Suppl 3):S40–S44PubMed
Metadata
Title
Effect of 5-HT2 Receptor Blockade on Cadmium-Induced Acute Toxicity
Authors
Konstantinos N. Tzirogiannis
Maria D. Demonakou
George K. Papadimas
Spyridon D. Skaltsas
Georgia A. Manta
Kalliopi T. Kourentzi
Katerina N. Alexandropoulou
Rosa I. Hereti
Michael G. Mykoniatis
Georgios I. Panoutsopoulos
Publication date
01-09-2007
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 9/2007
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-006-9132-2

Other articles of this Issue 9/2007

Digestive Diseases and Sciences 9/2007 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.